Хронический лимфолейкоз: литература
Byrd JC, et al. Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity. J Clin Oncol 2001; 19:2153.
Damle RN, et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced В lymphocytes. Blood 2002; 99:4087.
Dighiero G, et al. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med 1998; 338:1506.
Dohner H, et al. Genomic observations and survival in chronic lymphocytic leukemia. NEngJ Med 2000; 343:1910.
Hamblin TJ, et al. Unmutated IgV(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94:1848.
Mavromatis B, Cheson BD. Monoclonal antibody therapy of chronic lymphocytic leukemia. J Clin Oncol 2003; 21:1874.
O'Brien SM, et al. Rituximab dose-escalation trial in chronic lymphocytic leukemia. J Clin Oncol 2001; 19:2165.
Rai KR, et al. Fludarabine compared with chlorambucil as primary therapy to chronic lymphocytic leukemia. N Eng J Med 2000; 343:1750.
Weiss MA, et al. Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia. J Clin Oncol 2003; 21:1278.
Смотрите также:
